IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner

Arthritis and Rheumatism

Volumn 42, Issue 4, 1999, Pages 631-640

  Carvalho, Dulce ^a   Savage, Caroline O S ^c   Isenberg, David ^d   Pearson, Jeremy D ^b  

^a HOSPITAL GARCIA DE ORTA   (Portugal)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Dept of Environ/Occupational Med   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS;

ANTIBODIES, BLOCKING; AUTOANTIBODIES; AUTOCRINE COMMUNICATION; CELL ADHESION; CELL ADHESION MOLECULES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; U937 CELLS; UMBILICAL VEINS; VASCULITIS;

EID: 0032954179     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:4<631::AID-ANR5>3.0.CO;2-X     Document Type: Article

References (48)

1. Lindqvist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971;9:753-60.
2. Sordat B, Hess MW, Cottier H. IgG immunoglobulin in the wall of postcapillary venules: possible relationship to lymphocyte recirculation. Immunology 1971;20:115-8.
3. Carvalho D, Savage COS. Cytokines, adhesion molecules, antiendothelial cell autoantibodies and vascular disease. Cardiovasc Pathol 1997;6:61-78.
4. Del Papa N, Conforti G, Gambini D, La Rosa L, Tincani A, D'Cruz D, et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994;70:211-6.
5. Hill MB, Phipps JL, Malia RG, Greaves M, Hughes P. Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome. Clin Exp Immunol 1995;102:368-72.
6. Li JS, Liu MF, Lei HY. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity. Clin Immunol Immunopathol 1996;79:211-6.
7. Hill MB, Phipps JL, Cartwright RJ, Milford Ward A, Greaves M. Antibodies to membranes of endothelial cells and fibroblasts in scleroderma. Clin Exp Immunol 1996;106:491-7.
8. Hill MB, Phipps JL, Milford Ward A, Greaves M, Hughes P. Further characterization of anti-endothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting. Br J Rheumatol 1996;35:1231-8.
9. D'Cruz DP, Houssiau FA, Ramirez G, Baguley E, McCutcheon J, Vianna J, et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991;85:254-61.
10. Frampton G, Jayne DRW, Perry GJ, Lockwood CM, Cameron JS. Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1990;82:227-32.
11. Perry GJ, Elston T, Khouri NA, Chan TM, Cameron JS, Frampton G. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage. QJM 1993; 86:727-34.
12. Yoshio T, Masuyama JI, Sumiya M, Minota S, Kano S. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994;21: 2058-63.
13. Chan TM, Cheng IKP. A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996;78:41-6.
14. Gobel U, Eichhorn J, Kettritz R, Briedigkeit L, Sima D, Lindschau C, et al. Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis. Am J Kidney Dis 1996; 28:186-94.
15. Damianovich M, Gilburd B, George J, Del Papa N, Goldberg I, Kopolovic Y, et al. Pathogenic role of anti-endothelial cell antibodies in vasculitis: an idiotypic experimental model. J Immunol 1996;156:4946-51.
16. Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986;77:1428-35.
17. Leung DYM, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986;164:1958-64.
18. Leung DYM, Moake JL, Havens PL, Kim ML, Pober JS. Lytic antiendothelial cell antibodies in haemolytic-uraemic syndrome. Lancet 1988:ii:183-7.
19. Savage COS, Pottinger BE, Gaskin G, Lockwood CM, Pusey CD, Pearson JD. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol 1991;85:14-9.
20. Van der Zee JM, Miltenburg AM, Siegert CE, Daha MR, Breedveld FC. Antiendothelial cell antibodies in systemic lupus erythematosus: enhanced antibody binding to interleukin-1-stimulated endothelium. Int Arch Allergy Immunol 1994;104: 131-6.
21. Del Papa N, Meroni PL, Barcellini W, Sinico A, Radice A, Tincani A, et al. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 1992;63:267-74.
22. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986;137:1532-7.
23. Hasselaar P, Derksen RHWM, Oostings JD, Blokzijl L, de Groot PG. Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells. Thromb Haemost 1989;62:654-60.
24. Pearson JD, May MJ. Regulation of endothelial cell function by cytokines. In: Savage COS, Pearson JD, editors. Immunological aspects of the vascular endothelium. Cambridge: Cambridge University Press; 1995. p. 20-42.
25. Warner JC, Auger KR, Libby P. Interleukin induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by human vascular endothelial cells. J Immunol 1987;139: 1911-7.
26. Kurt-Jones EA, Fiers W, Pober JS. Membrane IL-1 induction on human endothelial cells and dermal fibroblasts. J Immunol 1987; 139:2317-24.
27. Pallis M, Robson DK, Haskard DO, Powell RJ. Distribution of cell adhesion molecule in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis 1993;52:667-71.
28. Belmont HM, Buyon J, Giorno R, Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus: the Shwartzman phenomenon revisited. Arthritis Rheum 1994;37:376-83.
29. Brady HR. Leukocyte adhesion molecules and kidney disease. Kidney Int 1994;45:1285-300.
30. Bleil L, Manger B, Winkler TH, Herrman M, Burmester GR, Krapf FE, et al. The role of antineutrophil cytoplasmic antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis. J Rheumatol 1991;18:1199-206.
31. Blann AD. von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease. J Rheumatol 1993; 20:1469-71.
32. Ohdama S, Takano S, Miyake S, Kubota T, Sato K, Aoki N. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular disease. Am J Clin Pathol 1994;101:109-13.
33. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CGM. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol 1994;97:439-44.
34. Hsu CD, Chan DW, Iriye B, Johnson TRB, Hong SF, Petri M. Plasma thrombomodulin levels in women with systemic lupus erythematosus. Am J Perinatol 1995;12:27-9.
35. Carvalho D, Savage COS, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro: induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996;97:111-9.
36. Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996;39:758-66.
37. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
38. Rosenbaum J, Pottinger BE, Woo P, Black CM, Byron MA, Pearson JD. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-6.
39. Hagen EC, Andrassy K, Csernok E, Daha MR, Gaskin G, Gross WL, et al. Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies. J Immunol Methods 1996;196:1-15.
40. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, et al. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988;74:247-53.
41. Chan TM, Yu PM, Tsang LC, Cheng IKP. Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations. Clin Exp Immunol 1995;100:506-13.
42. Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecule. Clin Exp Rheumatol 1995;13: 179-85.
43. Simantov R, LaSala J, Lo SK, Gharavi A, Sammaritano LR, Salmon JE, et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995;96:2211-9.
44. 2-glycoprotein I and induce endothelial cell activation. Arthritis Rheum 1997;40:551-61.
45. Mayet WJ, Meyer zum Buschenfelde K-D. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993;94:3:440-6.
46. Mayet WJ, Schwarting A, Orth T, Duchmann R, Meyer zum Buschenfelde K-D. Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin Exp Immunol 1996;103:259-67.
47. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993;82:1221-9.
48. King WJ, Adu D, Daha MR, Brooks CJ, Radford DJ, Pall AA, et al. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 1995;102: 98-105.